These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12220612)

  • 21. Criminal justice itreatment admissions for methamphetamine use in California: a focus on Proposition 36.
    Anglin MD; Urada D; Brecht ML; Hawken A; Rawson R; Longshore D
    J Psychoactive Drugs; 2007 Nov; Suppl 4():367-81. PubMed ID: 18284103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depression ratings, reported sexual risk behaviors, and methamphetamine use: latent growth curve models of positive change among gay and bisexual men in an outpatient treatment program.
    Jaffe A; Shoptaw S; Stein J; Reback CJ; Rotheram-Fuller E
    Exp Clin Psychopharmacol; 2007 Jun; 15(3):301-7. PubMed ID: 17563217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence and Therapy of Crystal Methamphetamine Dependence].
    Soyka M; Koller G; Proebstl L; Kamp F; Franke A; Schmidt P; Baumgärtner G; Schacht-Jablonowsky M; Sievert A; Straif M; Hamdorf W
    Fortschr Neurol Psychiatr; 2017 Feb; 85(2):92-99. PubMed ID: 28235211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methamphetamine treatment outcomes among gay men attending a LGBTI-specific treatment service in Sydney, Australia.
    Lea T; Kolstee J; Lambert S; Ness R; Hannan S; Holt M
    PLoS One; 2017; 12(2):e0172560. PubMed ID: 28207902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotherapeutic agents in the treatment of methamphetamine dependence.
    Morley KC; Cornish JL; Faingold A; Wood K; Haber PS
    Expert Opin Investig Drugs; 2017 May; 26(5):563-578. PubMed ID: 28351169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. METHAMPHETAMINE: WHERE WILL THE STAMPEDE TAKE US?
    Sullivan D; McDonough Michael
    J Law Med; 2015 Sep; 23(1):41-9. PubMed ID: 26554196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When treatment meets research: clinical perspectives from the CSAT Methamphetamine Treatment Project.
    Obert JL; Brown AH; Zweben J; Christian D; Delmhorst J; Minsky S; Morrisey P; Vandersloot D; Weiner A
    J Subst Abuse Treat; 2005 Apr; 28(3):231-7. PubMed ID: 15857723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain serotonin transporter in human methamphetamine users.
    Kish SJ; Fitzmaurice PS; Boileau I; Schmunk GA; Ang LC; Furukawa Y; Chang LJ; Wickham DJ; Sherwin A; Tong J
    Psychopharmacology (Berl); 2009 Mar; 202(4):649-61. PubMed ID: 18841348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in psychiatric symptoms among persons with methamphetamine dependence predicts changes in severity of drug problems but not frequency of use.
    Polcin DL; Korcha R; Bond J; Galloway G; Nayak M
    Subst Abus; 2016; 37(1):209-14. PubMed ID: 25775225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Getting Off: development of a model program for gay and bisexual male methamphetamine users.
    Reback CJ; Veniegas R; Shoptaw S
    J Homosex; 2014; 61(4):540-53. PubMed ID: 24245506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Social cognition and aggression in methamphetamine dependence with and without a history of psychosis.
    Uhlmann A; Ipser JC; Wilson D; Stein DJ
    Metab Brain Dis; 2018 Apr; 33(2):559-568. PubMed ID: 29224181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methamphetamine and psychiatry: A story of the colourless substance of abuse.
    Suetani S; Reddan J; Anderson C
    Australas Psychiatry; 2017 Jun; 25(3):254-256. PubMed ID: 28541728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nine session manual of motivational enhancement therapy for methamphetamine dependence: adherence and efficacy.
    Galloway GP; Polcin D; Kielstein A; Brown M; Mendelson J
    J Psychoactive Drugs; 2007 Nov; Suppl 4():393-400. PubMed ID: 18286727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Committee Opinion No. 479: Methamphetamine abuse in women of reproductive age.
    Obstet Gynecol; 2011 Mar; 117(3):751-755. PubMed ID: 21343793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parallel Effects of Methamphetamine on Anxiety and CCL3 in Humans and a Genetic Mouse Model of High Methamphetamine Intake.
    Huckans M; Wilhelm CJ; Phillips TJ; Huang ET; Hudson R; Loftis JM
    Neuropsychobiology; 2017; 75(4):169-177. PubMed ID: 29402784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An emerging problem: methamphetamine abuse among treatment seeking youth.
    Gonzales R; Ang A; McCann MJ; Rawson RA
    Subst Abus; 2008; 29(2):71-80. PubMed ID: 19042326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex Differences in Methamphetamine Use and Dependence in a Thai Treatment Center.
    Rungnirundorn T; Verachai V; Gelernter J; Malison RT; Kalayasiri R
    J Addict Med; 2017; 11(1):19-27. PubMed ID: 27649265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multisite study of the effectiveness of methamphetamine treatment: an initiative of the Center for Substance Abuse Treatment.
    Herrell JM; Taylor JA; Gallagher C; Dawud-Noursi S
    J Psychoactive Drugs; 2000; 32(2):143-7. PubMed ID: 10908001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions.
    Rose ME; Grant JE
    Ann Clin Psychiatry; 2008; 20(3):145-55. PubMed ID: 18633741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of patterns of methamphetamine and cocaine use.
    Simon SL; Richardson K; Dacey J; Glynn S; Domier CP; Rawson RA; Ling W
    J Addict Dis; 2002; 21(1):35-44. PubMed ID: 11831498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.